EMulate Therapeutics Announces the Incorporation of a Third Wholly Owned Subsidiary

Written By Kyle Kingma
Kyle Kingma
Previous

EMulate Therapeutics Announces Issuance Of 41st Patent Covering The Design Of A Pediatric Therapeutic Device For Cancer And Other Health Indications
Next

EMulate Therapeutics Issues White Paper Detailing Magnetic Field Effects Via Low and Ultra-Low Radio Frequency Energy (ulRFE(R))